D. N. Carney

Publication List Details

Period

1986 - 1986

Number

19

Co-Authors

Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.

Carney, D N, Bunn, P A, Gazdar, A F, Pagan, J A, Minna, J D

Fifteen tumor-containing specimens were obtained directly from patients with small cell carcinoma of the lung and tested for their ability to grow in serum-supplemented medium and in serum-free...

Human small-cell lung cancers show amplification and expression of the N-myc gene.

Nau, M M, Brooks, B J, Carney, D N, Gazdar, A F, Battey, J F, Sausville, E A, ...

We have found that 6 of 31 independently derived human small-cell lung cancer (SCLC) cell lines have 5- to 170-fold amplified N-myc gene sequences. The amplification is seen with probes from two...

Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.

Broers, J L, Carney, D N, De Ley, L, Vooijs, G P, Ramaekers, F C

The expression of intermediate filament proteins in classic and variant-type small-cell lung carcinoma (SCLC) cell lines was studied using immunocytochemical techniques, two-dimensional gel...

Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.

Carney, D N, Ahluwalia, G S, Jayaram, H N, Cooney, D A, Johns, D G

The antitumor activity of the antineoplastic agent, tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide), has previously been shown to require intracellular anabolism of the drug to a...

Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.

Johnson, B E, Battey, J, Linnoila, I, Becker, K L, Makuch, R W, Snider, R H, ...

Small cell lung cancer growing in cell culture possesses biologic properties that allow classification into two categories: classic and variant. Compared with classic small cell lung cancer cell...

Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.

Curt, G A, Jolivet, J, Carney, D N, Bailey, B D, Drake, J C, Clendeninn, N J, ...

We have characterized the determinants of methotrexate (MTX) responsiveness in eight patient-derived cell lines of small-cell lung cancer (SCLC). Clonogenic survival was correlated with factors known...

myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

Johnson, B E, Ihde, D C, Makuch, R W, Gazdar, A F, Carney, D N, Oie, H, ...

44 small cell lung cancer cell lines established from 227 patients were studied for myc family DNA amplification (c-myc, N-myc, and L-myc). Two of 19 lines (11%) established from untreated patients'...

Extrarenal malignancy and the nephrotic syndrome.

Heaton, J M, Menzin, M A, Carney, D N

The clinical and histological findings are described of a patient who presented with the nephrotic syndrome and was found at necropsy to have a bronchial carcinoma. Amyloidosis, renal vein...

Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.

Carney, D N, Bunn, P A, Gazdar, A F, Pagan, J A, Minna, J D

Fifteen tumor-containing specimens were obtained directly from patients with small cell carcinoma of the lung and tested for their ability to grow in serum-supplemented medium and in serum-free...

Human small-cell lung cancers show amplification and expression of the N-myc gene.

Nau, M M, Brooks, B J, Carney, D N, Gazdar, A F, Battey, J F, Sausville, E A, ...

We have found that 6 of 31 independently derived human small-cell lung cancer (SCLC) cell lines have 5- to 170-fold amplified N-myc gene sequences. The amplification is seen with probes from two...

Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.

Broers, J L, Carney, D N, De Ley, L, Vooijs, G P, Ramaekers, F C

The expression of intermediate filament proteins in classic and variant-type small-cell lung carcinoma (SCLC) cell lines was studied using immunocytochemical techniques, two-dimensional gel...

Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.

Carney, D N, Ahluwalia, G S, Jayaram, H N, Cooney, D A, Johns, D G

The antitumor activity of the antineoplastic agent, tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide), has previously been shown to require intracellular anabolism of the drug to a...

Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.

Johnson, B E, Battey, J, Linnoila, I, Becker, K L, Makuch, R W, Snider, R H, ...

Small cell lung cancer growing in cell culture possesses biologic properties that allow classification into two categories: classic and variant. Compared with classic small cell lung cancer cell...

Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.

Curt, G A, Jolivet, J, Carney, D N, Bailey, B D, Drake, J C, Clendeninn, N J, ...

We have characterized the determinants of methotrexate (MTX) responsiveness in eight patient-derived cell lines of small-cell lung cancer (SCLC). Clonogenic survival was correlated with factors known...

myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

Johnson, B E, Ihde, D C, Makuch, R W, Gazdar, A F, Carney, D N, Oie, H, ...

44 small cell lung cancer cell lines established from 227 patients were studied for myc family DNA amplification (c-myc, N-myc, and L-myc). Two of 19 lines (11%) established from untreated patients'...

Extrarenal malignancy and the nephrotic syndrome.

Heaton, J M, Menzin, M A, Carney, D N

The clinical and histological findings are described of a patient who presented with the nephrotic syndrome and was found at necropsy to have a bronchial carcinoma. Amyloidosis, renal vein...

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

Smit, E F, Carney, D N, Harford, P, Sleijfer, D T, Postmus, P E

Thirty five previously untreated patients with small cell lung cancer older than 70 years were treated with oral etoposide (800 mg/m2 over five consecutive days) every four weeks. Twenty two patients...

Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.

O'Byrne, K J, O'Hare, N J, Freyne, P J, Luke, D A, Clancy, L J, Prichard, J S, ...

Neuroendocrine tumours are characterised by the expression of high affinity binding sites for somatostatin. The detection of bronchial carcinoid tumours through scintigraphic imaging is described in...